Literature DB >> 28815459

A Roadmap for Reducing Cardiac Device Infections: a Review of Epidemiology, Pathogenesis, and Actionable Risk Factors to Guide the Development of an Infection Prevention Program for the Electrophysiology Laboratory.

Westyn Branch-Elliman1,2.   

Abstract

PURPOSE OF REVIEW: Cardiovascular implantable electronic device (CIED) infections are highly morbid, common, and costly, and rates are increasing (Sohail et al. Arch Intern Med 171(20):1821-8 2011; Voigt et al. J Am Coll Cardiol 48(3):590-1 2006). Factors that contribute to the development of CIED infections include patient factors (comorbid conditions, self-care, microbiome), procedural details (repeat procedure, contamination during procedure, appropriate pre-procedural prep, and antimicrobial use), environmental and organizational factors (patient safety culture, facility barriers, such as lack of space to store essential supplies, quality of environmental cleaning), and microbial factors (type of organism, virulence of organism). Each of these can be specifically targeted with infection prevention interventions. RECENT
FINDINGS: Basic prevention practices, such as administration of systemic antimicrobials prior to incision and delaying the procedure in the setting of fever or elevated INR, are helpful for day-to-day prevention of cardiac device infections. Small single-center studies provide proof-of-concept that bundled prevention interventions can reduce infections, particularly in outbreak settings. However, data regarding which prevention strategies are the most important is limited as are data regarding the optimal prevention program for day-to-day prevention (Borer et al. Infect Control Hosp Epidemiol 25(6):492-7 2004; Ahsan et al. Europace 16(10):1482-9 2014). Evolution of infection prevention programs to include ambulatory and procedural areas is crucial as healthcare delivery is increasingly provided outside of hospitals and operating rooms. The focus on traditional operating rooms and inpatient care leaves the vast majority of healthcare delivery-including cardiac device implantations in the electrophysiology laboratory-uncovered.

Entities:  

Keywords:  Cardiac device infection; Infection prevention and control; Quality improvement; Surveillance

Year:  2017        PMID: 28815459     DOI: 10.1007/s11908-017-0591-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  50 in total

1.  Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003.

Authors:  Andrew Voigt; Alaa Shalaby; Samir Saba
Journal:  J Am Coll Cardiol       Date:  2006-07-12       Impact factor: 24.094

2.  Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.

Authors:  Nasir Shariff; Elizabeth Eby; Evan Adelstein; Sandeep Jain; Alaa Shalaby; Samir Saba; Norman C Wang; David Schwartzman
Journal:  J Cardiovasc Electrophysiol       Date:  2015-05-25

3.  Analysis of neurosurgical reoperations: use of a surgical checklist and reduction of infection-related and preventable complication-related reoperations.

Authors:  Marjut Lepänluoma; Melissa Rahi; Riikka Takala; Eliisa Löyttyniemi; Tuija S Ikonen
Journal:  J Neurosurg       Date:  2015-02-27       Impact factor: 5.115

4.  A simple infection-control protocol to reduce serious cardiac device infections.

Authors:  Syed Y Ahsan; Bunny Saberwal; Pier D Lambiase; Chieh Y Koo; Simon Lee; Aerokondal B Gopalamurugan; Dominic P Rogers; Martin D Lowe; Anthony W C Chow
Journal:  Europace       Date:  2014-06-11       Impact factor: 5.214

5.  Implementation of Infection Prevention and Antimicrobial Stewardship in Cardiac Electrophysiology Laboratories: Results from the SHEA Research Network.

Authors:  Preeti Mehrotra; Kalpana Gupta; Judith Strymish; Daniel B Kramer; Anne Lambert-Kerzner; P Michael Ho; Westyn Branch-Elliman
Journal:  Infect Control Hosp Epidemiol       Date:  2017-01-20       Impact factor: 3.254

6.  Ambulatory surgery in the United States, 2006.

Authors:  Karen A Cullen; Margaret J Hall; Aleksandr Golosinskiy
Journal:  Natl Health Stat Report       Date:  2009-01-28

7.  Prevention of infections associated with permanent cardiac antiarrhythmic devices by implementation of a comprehensive infection control program.

Authors:  Abraham Borer; Jacob Gilad; Eytan Hyam; Francisc Schlaeffer; Pnina Schlaeffer; Seada Eskira; Phany Aloni; Abraham Wagshal; Amos Katz
Journal:  Infect Control Hosp Epidemiol       Date:  2004-06       Impact factor: 3.254

8.  How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.

Authors:  Maria Grazia Bongiorni; Germanas Marinskis; Gregory Y H Lip; Jesper Hastrup Svendsen; Dan Dobreanu; Carina Blomström-Lundqvist
Journal:  Europace       Date:  2012-11       Impact factor: 5.214

9.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors:  Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal:  Circulation       Date:  2010-01-04       Impact factor: 29.690

10.  Risk factors for mortality in patients with cardiac device-related infection.

Authors:  Timir S Baman; Sanjaya K Gupta; Javier A Valle; Elina Yamada
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-13
View more
  1 in total

1.  Cardiac implantable electronic device infection in the cardiac referral center in Thailand: incidence, microbiology, risk factors, and outcomes.

Authors:  Theerawat Korkerdsup; Tachapong Ngarmukos; Somnuek Sungkanuparph; Angsana Phuphuakrat
Journal:  J Arrhythm       Date:  2018-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.